■作为最常见的原发性肺肿瘤之一,非小细胞肺癌(NSCLC)由于其高转移率和不良预后结果而获得了相当大的研究兴趣.在不同的癌症类型中,代谢过程是肿瘤进展和生长所必需的,因此,干扰NSCLC中的此类过程可能在治疗上可行,以限制/阻止疾病进展。因此,理解代谢过程如何促进癌症的生长和生存机制,包括NSCLC,可能阐明支撑肿瘤细胞代谢的关键功能。然而,在这一领域还没有发表文献计量学分析,因此,我们在这里解决这个知识差距。
■2013年至2023年(12月28日),与NSCLC和代谢(NSCLC-Met)领域相关的文章从WebofScienceCoreCollection(WoSCC)检索.为了全面剖析NSCLC-Met的研究方向和文章,我们在R中使用了Bibliometrix包,VOSviewer和CiteSpace软件可直观地代表全球趋势和热点。
■在2013年至2023年之间,共检索到2246篇NSCLC-Met文章,呈持续上升趋势,逐年快速发展。癌症发表的文章最多,癌症研究记录了最高的平均引文数量。来自中国的张莉是最多产的作家,但最多的作者来自美国。中国,美国,和意大利是发表文章最多的三个国家,国家之间的密切合作。“肺腺癌”反映了最近的热点和研究方向,“免疫疗法”,\"nivolumab\",“检查点抑制剂”,\"封锁\",和“pembrolizumab”,而“肠道微生物组”,“egfr”和“剂量绘画”是研究人员的重要课题。
■根据我们的分析,科学家现在可以探索NSCLC-Met领域的新热点和研究方向。该领域的进一步深入研究无疑将为疾病诊断提供更多新的见解,治疗,和预测。
UNASSIGNED: As one of the most prevalent primary lung tumors, non-small cell lung cancer (
NSCLC) has garnered considerable research interest due to its high metastasis rates and poor prognosis outcomes. Across different cancer types, metabolic processes are required for tumors progression and growth, thus interfering with such processes in NSCLC may therapeutically viable for limiting/halting disease progression. Therefore, comprehending how metabolic processes contribute to growth and survival mechanisms in cancers, including
NSCLC, may elucidate key functions underpinning tumor cell metabolism. However, no bibliometric analyses have been published in this field, therefore we address this knowledge gap here.
UNASSIGNED: Between 2013 and 2023 (December 28th), articles related to the
NSCLC and metabolism (
NSCLC-Met) field were retrieved from the Web of Science Core Collection (WoSCC). To fully dissect NSCLC-Met research directions and articles, we used the Bibliometrix package in R, VOSviewer and CiteSpace software to visually represent global trends and hotspots.
UNASSIGNED: Between 2013 and 2023, 2,246
NSCLC-Met articles were retrieved, with a continuous upward trend and rapid development observed year on year. Cancers published the most articles, with Cancer Research recording the highest average citation numbers. Zhang Li from China was the most prolific author, but the highest number of authors came from the USA. China, USA, and Italy were the top three countries with the highest number of published articles, with close cooperation identified between countries. Recent hotspots and research directions were reflected by \"lung adenocarcinoma\", \"immunotherapy\", \"nivolumab\", \"checkpoint inhibitors\", \"blockade\", and \"pembrolizumab\", while \"gut microbiome\", \"egfr\" and \"dose painting\" were important topics for researchers.
UNASSIGNED: From our analyses, scientists can now explore new hotspots and research directions in the NSCLC-Met field. Further in-depth research in this field will undoubtedly provide more new insights on disease diagnostics, treatment, and prognostics.